Market Overview:
The global large volume wearable injectors market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in large volume wearable injectors. Based on type, the global large volume wearable injectors market is segmented into electronic injectors, mechanical injectors, and others. The electronic injector segment is expected to grow at a higher CAGR than other segments during the forecast period owing to its advantages such as accuracy and precision over other types of injection devices. Based on application, the global large volume wearable injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment application segment is expected to account for the largest share of the global large volume wearable injector market during the forecast period owing to increasing incidence of cancer across all regions worldwide.
Product Definition:
Large Volume Wearable Injectors are devices that allow for the injection of a large volume of fluid over an extended period of time. They are often used to deliver medication or other treatments directly to the bloodstream, which can improve their effectiveness and reduce side effects.
Electronical Injectors:
Electronic injectors are devices used to deliver medication through a catheter by using the flow of electrons. They work by creating an electrical field around the catheter which attracts and carries the medicine to be injected along with it. Electronic injectors have been approved for use in Europe, Canada, Australia, New Zealand and Japan.
Mechanical Injectors:
Mechanical injectors are devices used to inject a drug into the patient's body. They can be reusable or disposable depending on the type of drug being injected.
The mechanical injectors market is segmented based on product and application. The product segment is categorized as large volume wearable injector, small volume wearable injector, and auto-injector (small volume).
Application Insights:
The application segment includes cancer treatment, auto-immune treatment, blood disorders treatment, others and others. The other applications include diabetes mellitus type I & II and drug abuse. Cancer is expected to be the largest segment owing to increasing prevalence of cancer across the globe. Large volume wearable injectors are used for treating various cancers including breast cancer, lung cancer, colon/rectalcancer and prostate cancer among others.
Cancer is followed by autoimmune disease which accounts for 20% of global revenue share in 2017 due to high incidence rate of chronic diseases such as multiple sclerosis (MS), rheumatoid arthritis (RA) & osteoarthritis (OA). Increasing R&D activities pertaining to large-volume delivery systems that can specifically target tumor cells while minimizing damage to healthy tissues may boost growth prospects over the forecast period.
Regional Analysis:
North America dominated the market in 2017 owing to the presence of major players such as Medtronic, B. Braun Melsungen AG, and Johnson & Johnson. The region is expected to maintain its dominance over the forecast period due to increasing geriatric population base and rising incidences of chronic diseases that require large volume wearable injectors for treatment.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to a rise in diabetic patients requiring insulin therapy along with an increase in cancer patients seeking large volume wearable injectors for treatment across countries such as China, India, Japan, South Korea & Australia among others. In addition there has been a significant rise in investments by prominent players for expansion into emerging economies thereby driving growth across this region over next eight years (2030).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Large volume wearable injectors can help in delivering drugs to patients with chronic diseases in a more efficient and timely manner, thus improving their quality of life.
- Growing demand for self-injection devices: There has been a growing demand for self-injection devices in recent years, as they offer patients greater convenience and privacy than traditional injections administered by healthcare professionals. Large volume wearable injectors are well suited for use in self-injection applications, and this is likely to drive their growth in the coming years.
- Technological advancements: The field of large volume wearable injectors is constantly evolving, with new technological advancements being made on a regular basis. This has led to the development of more sophisticated and user-friendly devices that are capable of delivering drugs accurately and efficiently into the body tissues or organs affected by disease or injury.. Such technological advances are likely to fuel market growth over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Large Volume Wearable Injectors Market Research Report
By Type
Electronical Injectors, Mechanical Injectors, Others,
By Application
Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, Others,
By Companies
West, Unilife, CeQur, Sensile Medical, BD Medical, Enable Injections, Roche, ScPharmaceuticals, SteadyMed, J & J
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Large Volume Wearable Injectors Market Report Segments:
The global Large Volume Wearable Injectors market is segmented on the basis of:
Types
Electronical Injectors, Mechanical Injectors, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Treatment, Auto-immune Treatment, Blood Disorders Treatment, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- West
- Unilife
- CeQur
- Sensile Medical
- BD Medical
- Enable Injections
- Roche
- ScPharmaceuticals
- SteadyMed
- J & J
Highlights of The Large Volume Wearable Injectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Electronical Injectors
- Mechanical Injectors
- Others
- By Application:
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Large Volume Wearable Injectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Large volume wearable injectors are medical devices that allow for the continuous infusion of medications into a patient's body. They are typically used to treat conditions such as cancer, heart disease, and diabetes.
Some of the major companies in the large volume wearable injectors market are West, Unilife, CeQur, Sensile Medical, BD Medical, Enable Injections, Roche, ScPharmaceuticals, SteadyMed, J & J.
The large volume wearable injectors market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Large Volume Wearable Injectors Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Large Volume Wearable Injectors Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Large Volume Wearable Injectors Market - Supply Chain
4.5. Global Large Volume Wearable Injectors Market Forecast
4.5.1. Large Volume Wearable Injectors Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Large Volume Wearable Injectors Market Size (000 Units) and Y-o-Y Growth
4.5.3. Large Volume Wearable Injectors Market Absolute $ Opportunity
5. Global Large Volume Wearable Injectors Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Large Volume Wearable Injectors Market Size and Volume Forecast by Type
5.3.1. Electronical Injectors
5.3.2. Mechanical Injectors
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Large Volume Wearable Injectors Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Large Volume Wearable Injectors Market Size and Volume Forecast by Application
6.3.1. Cancer Treatment
6.3.2. Auto-immune Treatment
6.3.3. Blood Disorders Treatment
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Large Volume Wearable Injectors Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Large Volume Wearable Injectors Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Large Volume Wearable Injectors Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Large Volume Wearable Injectors Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Large Volume Wearable Injectors Demand Share Forecast, 2019-2026
9. North America Large Volume Wearable Injectors Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Large Volume Wearable Injectors Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Large Volume Wearable Injectors Market Size and Volume Forecast by Application
9.4.1. Cancer Treatment
9.4.2. Auto-immune Treatment
9.4.3. Blood Disorders Treatment
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Large Volume Wearable Injectors Market Size and Volume Forecast by Type
9.7.1. Electronical Injectors
9.7.2. Mechanical Injectors
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Large Volume Wearable Injectors Demand Share Forecast, 2019-2026
10. Latin America Large Volume Wearable Injectors Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Large Volume Wearable Injectors Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Large Volume Wearable Injectors Market Size and Volume Forecast by Application
10.4.1. Cancer Treatment
10.4.2. Auto-immune Treatment
10.4.3. Blood Disorders Treatment
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Large Volume Wearable Injectors Market Size and Volume Forecast by Type
10.7.1. Electronical Injectors
10.7.2. Mechanical Injectors
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Large Volume Wearable Injectors Demand Share Forecast, 2019-2026
11. Europe Large Volume Wearable Injectors Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Large Volume Wearable Injectors Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Large Volume Wearable Injectors Market Size and Volume Forecast by Application
11.4.1. Cancer Treatment
11.4.2. Auto-immune Treatment
11.4.3. Blood Disorders Treatment
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Large Volume Wearable Injectors Market Size and Volume Forecast by Type
11.7.1. Electronical Injectors
11.7.2. Mechanical Injectors
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Large Volume Wearable Injectors Demand Share, 2019-2026
12. Asia Pacific Large Volume Wearable Injectors Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Large Volume Wearable Injectors Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Large Volume Wearable Injectors Market Size and Volume Forecast by Application
12.4.1. Cancer Treatment
12.4.2. Auto-immune Treatment
12.4.3. Blood Disorders Treatment
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Large Volume Wearable Injectors Market Size and Volume Forecast by Type
12.7.1. Electronical Injectors
12.7.2. Mechanical Injectors
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Large Volume Wearable Injectors Demand Share, 2019-2026
13. Middle East & Africa Large Volume Wearable Injectors Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Large Volume Wearable Injectors Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Large Volume Wearable Injectors Market Size and Volume Forecast by Application
13.4.1. Cancer Treatment
13.4.2. Auto-immune Treatment
13.4.3. Blood Disorders Treatment
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Large Volume Wearable Injectors Market Size and Volume Forecast by Type
13.7.1. Electronical Injectors
13.7.2. Mechanical Injectors
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Large Volume Wearable Injectors Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Large Volume Wearable Injectors Market: Market Share Analysis
14.2. Large Volume Wearable Injectors Distributors and Customers
14.3. Large Volume Wearable Injectors Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. West
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Unilife
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CeQur
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sensile Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BD Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Enable Injections
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ScPharmaceuticals
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. SteadyMed
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. J & J
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
